Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome

VARLI B., ŞÜKÜR Y. E., ÖZMEN B., Ergüder B. İ., SÖNMEZER M., BERKER B., ...Daha Fazla

CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE, cilt.48, sa.4, ss.368-373, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5653/cerm.2021.04420
  • Dergi Adı: CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier
  • Sayfa Sayıları: ss.368-373
  • Anahtar Kelimeler: Assisted reproductive technique, Leptin, Nesfatin, Obestatin, Polycystic ovary syndrome, ENDOTHELIAL GROWTH-FACTOR, FOLLICULAR-FLUID LEVELS, GHRELIN, WOMEN, FERTILIZATION, INSULIN, SERUM, GENE
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: In this study we aimed to assess anorexigenic peptide levels in patients with or without polycystic ovary syndrome (PCOS) and their effects on assisted reproductive treatment (ART) outcomes.